Stryker Corp.'s biotech division and four current and former executives have been indicted on federal fraud charges related to their marketing of two bone-growth products.
Stryker Charged with Marketing FraudCourtesy MedPage Today Surgery Thu, 10/29/2009 - 12:49
Stryker Corp.'s biotech division and four current and former executives have been indicted on federal fraud charges related to their marketing of two bone-growth products. More related itemsSpine Surgeons React to BMP-2 Cancer Data
Sunscreen must protect against UVA and UVB rays or...
Botox maker to pay $600M to resolve investigation
|
Popular by tags Week
Month |
Post new comment